Executive management

CFO since 2022 and interim CEO since 2025
Born 1978
MSc in electrical engineering from the Royal Institute of Technology and MSc in economics from Stockholm University.
Owner of Calan Consulting AB.
CEO at Careium AB, CEO and CFO at DORO AB, CFO at Lekolar, Vice President Business Development at Beijer Electronics, and consultant at Capgemini Invent.
5,142 ordinary shares.
Allotted 160,000 employee stock options under LTI 2024.

CEO of Nextmune since 2017
Born 1973
MSc in Business and Economics from the Stockholm School of Economics.
Chairman and member of the board in a number of subsidiaries within the Group including Nextmune Holding BV, Nextmune BV, Nextmune US LLC, Nextmune AS, Nextmune Scandinavia AB, Nextmune Spain S.L., Nextmune Italy S.r.l., Vetruus Limited and Bova UK Limited.
VP Corporate Strategy and M&A at Meda.
3,426,047 ordinary shares.
Allotted 150,000 employee stock options under LTI 2024.

CEO of VetFamily since 2022 and interim Head of MedTech since 2025
Born 1983
MSc in Economics and Business Administration from the Stockholm School of Economics.
Chairman of the board and board member of a number of subsidiaries within the Group. Board member of Famano AB, Precis Holding AB (Precis Digital), Seenthis AB, Proxer Midco AB and Stiftelsen Vin & Sprithistoriska museet.
Group CEO of Omnicom Media Group Sweden, COO MTGx and Head of Digital MTG
Chairman of the Board OMD Sweden, Chairman of the Board PHD Sweden, Chairman of the Board Hearts & Science Sweden, Chairman of the Board Drum Sweden. Member of Board Splay Networks & Member of Board Godsmak.se.
299,638 ordinary shares and 125,170 C shares.
Subscribed for a total of 10,000 warrants in the Company under LTI 2023.
Allotted 135,000 employee stock options under LTI 2024.

CEO of Indical Bioscience since 2021
Born 1981
MSc in Economics and Business Administration (Honours) at LUISS Guido Carli University in Rome.
Board member of Telenostic Limited, Board member of a number of subsidiaries within the Group.
Ontario Teachers’ Pension Plan (OTPP), Bain & Company, TIM Telecom Italia, P&G.
4,500 ordinary shares.
Subscribed for a total of 81,905 warrants and 4,095 employee stock options under LTI 2023.
Allotted 100,000 employee stock options under LTI 2024.

Head of M&A since 2021
Born 1981
MSc in Finance from the Stockholm School of Economics.
Board member of HRR Holding AB and Danzinger Gatt Invest AB.
Head of M&A at Doktor.se, Group M&A Manager at AniCura and Investment Manager at Nordic Capital.
282,802 ordinary shares.
0 warrants.
Allotted 60,000 employee stock options under LTI 2024.

Head of IR, Communications & Sustainability since 2021
Born 1981
MSc in Accounting and Financial Management from the Stockholm School of Economics.
Group Communications Director at AniCura, Head of Marketing & Communications at Moderna Försäkringar and Consultant at JKL Group.
8,342 ordinary shares.
Subscribed for a total of 80,000 warrants under LTI 2023.
Allotted 143,612 employee stock options under LTI 2024.

General Counsel since 2022
Born 1974
Master of laws - LLM from Lund University
Bachelor of Business Administration – Finance from Lund University
Board member of Elding Oscarson Arkitekter AB
Board member of Tapster AB
Vice President and Chief Counsel International Operations at Zoetis
Assistant General Counsel at Pfizer
Attorney (Advokat) at Mannheimer Swartling Law Firm
19,660 ordinary shares.
Subscribed for a total of 50,000 warrants in the Company under LTI 2023.
Allotted 70,000 employee stock options under LTI 2024.

Chief People Officer since 2023
Born 1985
MSc Economic Geography from University of Groningen
Bachelor of Business Administration Management, Economics & Law from Hanze University of Applied Sciences, Groningen
Deputy CEO at Edward Lynx management consulting
Allotted 70 000 personaloptioner under LTI 2024.